Antiestrogen resistance: mechanisms by which breast cancer cells undermine the effectiveness of endocrine therapy
- PMID: 1920488
- DOI: 10.1093/jnci/83.20.1434
Antiestrogen resistance: mechanisms by which breast cancer cells undermine the effectiveness of endocrine therapy
Comment on
-
Acquired tamoxifen resistance: correlation with reduced breast tumor levels of tamoxifen and isomerization of trans-4-hydroxytamoxifen.J Natl Cancer Inst. 1991 Oct 16;83(20):1477-82. doi: 10.1093/jnci/83.20.1477. J Natl Cancer Inst. 1991. PMID: 1920493
Similar articles
-
Molecular mechanisms of resistance to tamoxifen therapy in breast cancer.Arch Surg. 1993 Nov;128(11):1187-91. doi: 10.1001/archsurg.1993.01420230015002. Arch Surg. 1993. PMID: 8239980 Review.
-
[Molecular aspects of different mechanisms of tamoxifen resistance].Bull Cancer. 1997 Jan;84(1):69-75. Bull Cancer. 1997. PMID: 9180863 Review. French.
-
[Effects and mechanism of action of antiestrogens in breast cancer].Sem Hop. 1984 Mar 1;60(10):703-9. Sem Hop. 1984. PMID: 6322320 Review. French.
-
Antiestrogen-estrogen receptor interactions.Cancer Treat Res. 1996;83:213-24. doi: 10.1007/978-1-4613-1259-8_11. Cancer Treat Res. 1996. PMID: 8826649 Review. No abstract available.
-
Resistance to tamoxifen with persisting sensitivity to estrogen: possible mediation by excessive antiestrogen binding site activity.Cancer Res. 1992 Aug 1;52(15):4106-12. Cancer Res. 1992. PMID: 1638522
Cited by
-
The quinone reductase gene: a unique estrogen receptor-regulated gene that is activated by antiestrogens.Proc Natl Acad Sci U S A. 1997 Mar 18;94(6):2581-6. doi: 10.1073/pnas.94.6.2581. Proc Natl Acad Sci U S A. 1997. PMID: 9122238 Free PMC article.
-
Mechanisms of resistance to structurally diverse antiestrogens differ under premenopausal and postmenopausal conditions: evidence from in vitro breast cancer cell models.Endocrinology. 2009 May;150(5):2036-45. doi: 10.1210/en.2008-1195. Epub 2009 Jan 29. Endocrinology. 2009. PMID: 19179445 Free PMC article.
-
Measurement of steroid hormone receptors in breast cancer patients on tamoxifen.Breast Cancer Res Treat. 1993;26(3):237-46. doi: 10.1007/BF00665801. Breast Cancer Res Treat. 1993. PMID: 8251648
-
Effects of psoralens as anti-tumoral agents in breast cancer cells.World J Clin Oncol. 2014 Aug 10;5(3):348-58. doi: 10.5306/wjco.v5.i3.348. World J Clin Oncol. 2014. PMID: 25114850 Free PMC article. Review.
-
The Wilms' tumor suppressor WT1 induces estrogen-independent growth and anti-estrogen insensitivity in ER-positive breast cancer MCF7 cells.Oncol Rep. 2010 Apr;23(4):1109-17. doi: 10.3892/or_00000739. Oncol Rep. 2010. PMID: 20204298 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical